SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-074154
Filing Date
2016-01-05
Accepted
2016-01-05 17:46:24
Documents
1
Period of Report
2016-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v428260_4.html 4  
1 OWNERSHIP DOCUMENT v428260_4.xml 4 6078
  Complete submission text file 0001144204-16-074154.txt   7593
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Issuer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O TWINLAB CONSOLIDATED HOLDINGS, INC. 632 BROADWAY, SUITE 201 NEW YORK NY 10012
Business Address
Wolfson Glenn C (Reporting) CIK: 0001627230 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55181 | Film No.: 161324098